RAN and hyperinsulinism: Although a subset of Ran transgenic mice were asymptomatic (∼40%) at the time of diabetic onset (2 mo), these animals also revealed reduced islet number and islet mass, compensatory hyperinsulinemia, and impaired insulin response to glucose stimulation of isolated islets, in vitro.